Clinical Trials Browser

Phase 1/2 × Unknown × Adenocarcinoma of Lung × Clear all

NCT05079022 2021-10-15

ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas

Phase 1/2 Unknown

Adenocarcinoma of Lung, Neoplasm, Residual

NCT03298763 2021-04-28

TACTICAL

Phase 1/2 Unknown

Adenocarcinoma of Lung